HTLV-1, HTLV-2, and associated diseases
More emphasis on infectious complications of HTLV-1; additional detail of occurrence and disease outcomes of HTLV-2.
Addition of recent information on HTLV-1 receptor, virological synapse, the regulatory protein HBZ, and FoxP3+CD4+ T cells.
Discussion on reliability of prevalence estimates.
Particle agglutination tests have gone out of use and are no longer mentioned.
The proposal of a fifth category of ATL has not been adopted widely and is no longer mentioned.
Addition of bronchiectasis to table.
Addition of potential treatment strategies proposed in the literature.
Enhanced discussion of infectious complications and non-HAM/TSP inflammatory conditions.
More detail on HTLV-2 disease outcomes.
Recent references have been added.
Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.